2 211

Cited 25 times in

Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma

DC FieldValueLanguage
dc.contributor.author김경식-
dc.contributor.author박영년-
dc.contributor.author임진홍-
dc.contributor.author최기홍-
dc.contributor.author최진섭-
dc.date.accessioned2015-01-06T17:01:07Z-
dc.date.available2015-01-06T17:01:07Z-
dc.date.issued2014-
dc.identifier.issn0748-7983-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/99212-
dc.description.abstractBACKGROUND: The 7th American Joint Committee on Cancer (AJCC) currently classifies combined hepatocellular-cholangiocarcinoma (cHCC-CC) and intrahepatic cholangiocarcinoma (ICC) into one category. Study outcomes comparing the two carcinomas have shown contrary results. This study was designed to compare the survival and prognostic factors of both carcinomas. METHODS:We retrospectively reviewed the medical records of 107 patients with cHCC-CC or ICC who underwent liver resection between January 2000 and December 2009. RESULTS:Thirty patients (28%) were diagnosed with cHCC-CC, and 77 patients (72%) had ICC. Disease-free survival (DFS) was poorer in the cHCC-CC patients (six months), and the overall survival (OS) durations were similar (p = 0.477) between cHCC-CC (58 months) and ICC (45 months) patients. A tumor size larger than 5 cm, vascular invasion and lymph node (LN) metastasis were prognostic factors in all patients. However, tumor size and LN metastasis in cHCC-CC patients and carbohydrate antigen 19-9, differentiation and LN metastasis in ICC patients were found to be independent prognostic factors. CONCLUSIONS:Patients with cHCC-CC showed poorer DFS and similar OS rates compared to those with ICC. Our study revealed different prognostic factors in cHCC-CC. To understand more accurately cHCC-CC's prognosis, difference of genetic characteristics and tumor biology should be further evaluated.-
dc.description.statementOfResponsibilityopen-
dc.format.extent976~981-
dc.relation.isPartOfEJSO-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHBile Duct Neoplasms-
dc.subject.MESHBile Ducts, Intrahepatic-
dc.subject.MESHCarcinoma, Hepatocellular/diagnosis*-
dc.subject.MESHCarcinoma, Hepatocellular/mortality*-
dc.subject.MESHCarcinoma, Hepatocellular/pathology-
dc.subject.MESHCarcinoma, Hepatocellular/surgery-
dc.subject.MESHCholangiocarcinoma/diagnosis*-
dc.subject.MESHCholangiocarcinoma/mortality*-
dc.subject.MESHCholangiocarcinoma/pathology-
dc.subject.MESHCholangiocarcinoma/surgery-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHHepatectomy-
dc.subject.MESHHumans-
dc.subject.MESHLiver Neoplasms/diagnosis*-
dc.subject.MESHLiver Neoplasms/mortality*-
dc.subject.MESHLiver Neoplasms/pathology-
dc.subject.MESHLiver Neoplasms/surgery-
dc.subject.MESHLymphatic Metastasis-
dc.subject.MESHMale-
dc.subject.MESHMedical Records-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoplasm Invasiveness-
dc.subject.MESHPrognosis-
dc.subject.MESHRepublic of Korea/epidemiology-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHRisk Factors-
dc.subject.MESHSample Size-
dc.subject.MESHSurvival Analysis-
dc.subject.MESHTreatment Outcome-
dc.titleCharacteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학)-
dc.contributor.googleauthorS.H. Kim-
dc.contributor.googleauthorY.N. Park-
dc.contributor.googleauthorJ.H. Lim-
dc.contributor.googleauthorG.H. Choi-
dc.contributor.googleauthorJ.S. Choi-
dc.contributor.googleauthorK.S. Kim-
dc.identifier.doi10.1016/j.ejso.2014.04.016-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00299-
dc.contributor.localIdA01563-
dc.contributor.localIdA03411-
dc.contributor.localIdA04046-
dc.contributor.localIdA04199-
dc.relation.journalcodeJ00847-
dc.identifier.eissn1532-2157-
dc.identifier.pmid24909336-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0748798314004582-
dc.subject.keywordCholangiocarcinoma-
dc.subject.keywordHepatocellular carcinoma-
dc.subject.keywordTumor size-
dc.contributor.alternativeNameKim, Kyung Sik-
dc.contributor.alternativeNamePark, Young Nyun-
dc.contributor.alternativeNameLim, Jin Hong-
dc.contributor.alternativeNameChoi, Gi Hong-
dc.contributor.alternativeNameChoi, Jin Sub-
dc.contributor.affiliatedAuthorKim, Kyung Sik-
dc.contributor.affiliatedAuthorPark, Young Nyun-
dc.contributor.affiliatedAuthorLim, Jin Hong-
dc.contributor.affiliatedAuthorChoi, Gi Hong-
dc.contributor.affiliatedAuthorChoi, Jin Sub-
dc.rights.accessRightsfree-
dc.citation.volume40-
dc.citation.number8-
dc.citation.startPage976-
dc.citation.endPage981-
dc.identifier.bibliographicCitationEJSO, Vol.40(8) : 976-981, 2014-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.